Afuresertib (GSK2110183), an oral AKT kinase inhibitor, in combination with carboplatin and paclitaxel in recurrent ovarian cancer

S. Blagden, A. Hamilton, Linda Mileshkin, M. Hall, T. Meniawy, S. Wong, S. Anandra, M. Buck, D. McAleer, B. A. Reedy, R. B. Noble, D. A. Smith, S. R. Morris, H. Gabra

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)7-7
Number of pages1
JournalEuropean Journal of Cancer
Publication statusPublished - Nov 2014
Event26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Barcelona, Spain
Duration: 18 Nov 201421 Nov 2014

Cite this